Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
2(67%)
Results Posted
100%(1 trials)

Phase Distribution

Ph not_applicable
1
33%
Ph early_phase_1
1
33%
Ph phase_2
1
33%

Phase Distribution

1

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Early Phase 1First-in-human
1(33.3%)
Phase 2Efficacy & side effects
1(33.3%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

3

all time

Status Distribution
Active(2)
Completed(1)

Detailed Status

Recruiting1
Active, not recruiting1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
2
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (33.3%)
Phase 21 (33.3%)
N/A1 (33.3%)

Trials by Status

recruiting133%
active_not_recruiting133%
completed133%

Recent Activity

2 active trials
Showing 3 of 3
completedearly_phase_1

Human Amniotic Membrane to Decrease Post Operative Atrial Fibrillation

NCT04130061
active_not_recruitingnot_applicable

3D Analysis of Soft Tissue Healing After Immediate Implant Placement Using PRF Vs HAM

NCT06834802
recruitingphase_2

Human Amniotic Membrane (hAM) for Stage II Maxillomandibular Osteonecrosis Management

NCT05664815

Clinical Trials (3)

Showing 3 of 3 trials
NCT04130061Early Phase 1

Human Amniotic Membrane to Decrease Post Operative Atrial Fibrillation

Completed
NCT06834802Not Applicable

3D Analysis of Soft Tissue Healing After Immediate Implant Placement Using PRF Vs HAM

Active Not Recruiting
NCT05664815Phase 2

Human Amniotic Membrane (hAM) for Stage II Maxillomandibular Osteonecrosis Management

Recruiting

All 3 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
3